Stockscreener 앱 받기
323.50
0.14%
-0.3647
Penumbra Inc 주식(PEN)의 최신 뉴스
Penumbra earnings in focus as Boston Scientific deal looms - Investing.com
MSN Money - MSN
Vanguard Group Inc. Cuts Stock Position in Penumbra, Inc. $PEN - MarketBeat
Inside Boston Scientific's $15 billion offer for Alameda's largest employer - The Business Journals
PEN Stock Price, Quote & Chart | PENUMBRA INC (NYSE:PEN) - ChartMill
Penumbra, Inc. (NYSE:PEN) Sees Large Drop in Short Interest - MarketBeat
Vanguard Capital Management (NYSE: PEN) holds 1.99M shares, 5.07% stake - Stock Titan
[ARS] Penumbra Inc SEC Filing - Stock Titan
Penumbra (PEN) down 1.6% since last earnings report: Can it rebound? - MSN
Penumbra (NYSE: PEN) outlines 2026 meeting and $14.5B Boston Scientific sale - Stock Titan
Teacher Retirement System of Texas Reduces Stake in Penumbra, Inc. $PEN - MarketBeat
3 Reasons Why Penumbra (PEN) Is a Great Growth Stock - Yahoo Finance
Investor Outlook: Penumbra, Inc. (PEN) Eyes 10.88% Upside With Strong Revenue Growth - DirectorsTalk Interviews
Why (PEN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
How STORM-PE Thrombectomy Results and Lightning Flash Data Will Impact Penumbra (PEN) Investors - simplywall.st
Penumbra Deadline Alert - TMX Newsfile
Q3 2025 Penumbra Inc Earnings Call Transcript - GuruFocus
Penumbra Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
M&T Bank Corp Grows Position in Penumbra, Inc. $PEN - MarketBeat
Penumbra names Shruthi Narayan as president, effective September 1 - MSN
Penumbra (PEN) urges shareholders to approve Boston Scientific merger May 6 - Stock Titan
Boston Scientific to acquire Penumbra for enterprise value of ~$14.5B - MSN
Penumbra (PEN) Deep Dive | Q4 2025: Profit Exceeds ViewsNCAV - Xã Thanh Hà
Penumbra vote May 7 as Boston Scientific (NYSE: PEN) aims H2 2026 close - Stock Titan
Neurovascular Microcatheter Market Is Going to Boom Rapidly | Medtronic, Penumbra, Stryker - openPR.com
Penumbra, Inc. (PEN) Stock Analysis: A Healthcare Contender With 10% Upside Potential - DirectorsTalk Interviews
Penumbra Inc stock (US70975L1070): Why Google Discover changes matter more now - AD HOC NEWS
Penumbra (PEN) Stock: Why Strong Balance Sheet (Momentum Building) 2026-04-18Rating Change - Cổng thông tin điện tử Tỉnh Sơn La
Form 425Prospectuses and communications, business combinations - ADVFN
FTC Issues Second Request for Boston Scientific and Penumbra Merger - HarianBasis.co
Penumbra Inc (NYSE:PEN) Presents a Compelling Growth and Breakout Opportunity - ChartMill
Board backs Boston Scientific acquisition of Penumbra (PEN); Special Meeting May 6, 2026 - Stock Titan
Penumbra, Inc. (NYSE:PEN) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Did STORM-PE’s Strong Functional Outcomes Just Shift Penumbra's (PEN) Investment Narrative? - Sahm
Understanding Momentum Shifts in (PEN) - Stock Traders Daily
Boston Scientific’s $14.9 Billion Bet: The Strategic "Homecoming" to Neurovascular Dominance - FinancialContent
Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A - The Chronicle-Journal
Here's Why Penumbra (PEN) is a Strong Growth Stock - Yahoo Finance
A Look At Boston Scientific (BSX) Valuation After The Penumbra Acquisition And Recent Shareholder Returns - Yahoo Finance
Penumbra (PEN) to Release Quarterly Earnings on Wednesday - MarketBeat
RBC Capital Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $374 - Moomoo
Penumbra Inc stock (US70975L1070): Why its neurovascular leadership matters more now for investors - AD HOC NEWS
Penumbra Presents STORM-PE 90-day Results at SIR - dicardiology.com
Penumbra trial shows improved outcomes for pulmonary embolism By Investing.com - Investing.com Australia
Study backs Penumbra computer-assisted thrombectomy - MassDevice
Penumbra (PEN) Reports Positive Outcomes from STORM-PE Trial - GuruFocus
Aug PreEarnings: What is the long term forecast for Penumbra Inc stock2026 WrapUp & Weekly High Momentum Picks - baoquankhu1.vn
0.76%
0.72%
자본화:
|
볼륨(24시간):